Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Industrial Estimate
Composite Estimate
500 Stocks Estimate
Gold
Crude Oil
Central Oregon Stock Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
AbbVie
(NY:
ABBV
)
214.35
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EST, Jan 16, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
-
Bid (Size)
214.50 (100)
Ask (Size)
214.70 (100)
Prev. Close
214.35
Today's Range
214.35 - 214.35
52wk Range
164.39 - 244.81
Shares Outstanding
N/A
Dividend Yield
3.06%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever
↗
Today 4:05 EST
Income investors can rely on these stocks.
Via
The Motley Fool
Topics
Intellectual Property
The Smartest Dividend Stocks to Buy in 2026 With $1,000 Right Now -- Including Realty Income and AbbVie
↗
Today 0:50 EST
These stocks sport dividend yields ranging from 2.9% to 5.5%.
Via
The Motley Fool
Performance
YTD
-6.5%
-6.5%
1 Month
-5.5%
-5.5%
3 Month
-7.6%
-7.6%
6 Month
+16.0%
+16.0%
1 Year
+24.2%
+24.2%
More News
Read More
Could Buying This Stock Today Pay Off Big Over the Next 5 Years?
↗
January 18, 2026
Via
The Motley Fool
Topics
Intellectual Property
AbbVie Call Options Spike 2,599%: Tracking the Big Bet
↗
January 16, 2026
Via
MarketBeat
AbbVie Seeks To Grow Obesity Drug Portfolio — Retail Touts Drugmaker As Big Competition To Lilly
↗
January 14, 2026
Via
Stocktwits
Genmab Reports Mixed Results From Late-Stage Trial Of Lymphoma Drug
↗
January 16, 2026
Via
Stocktwits
3 Absurdly Cheap Growth Stocks to Buy in 2026
↗
January 15, 2026
Via
The Motley Fool
Healthcare Titan Ascendant: Johnson & Johnson Hits All-Time Highs as It Navigates a New Political and Clinical Era
January 15, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Bankruptcy
Earnings
Nasdaq, S&P 500 Futures Edge Lower Ahead Of CPI, JPMorgan Earnings: Why MSFT, NVDA, ABBV, ABAT Are Also On Traders' Radar Today
↗
January 13, 2026
Via
Stocktwits
Topics
Artificial Intelligence
Credit Cards
ETFs
Revolution Medicines Dismisses Merck, Abbvie Buyout Talks While Analyst Say It Is Worth More Than $32B
↗
January 12, 2026
Via
Stocktwits
The AI-Bio Convergence: Lilly and Nvidia Kick Off JPM26 with Landmark $1 Billion Alliance
January 12, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Intellectual Property
3 No-Brainer Dividend Stocks to Buy Right Now
↗
January 12, 2026
Via
The Motley Fool
Topics
Intellectual Property
This ETF Is Proof That the Healthcare Rebound Is Real
↗
January 11, 2026
Via
MarketBeat
Topics
ETFs
Eli Lilly Solidifies Immunology Dominance with $1.2 Billion Acquisition of Ventyx Biosciences
January 09, 2026
Via
MarketMinute
2 Healthcare Stocks That Can Diversify a Tech-Heavy Portfolio
↗
January 09, 2026
Via
The Motley Fool
Topics
Economy
Intellectual Property
Lawsuit
MoonLake Immunotherapeutics Surges as FDA "De-Risks" Sonelokimab, Reigniting Multi-Billion Dollar Takeover Speculation
January 09, 2026
Via
MarketMinute
Topics
Intellectual Property
The $20 Billion Question: Revolution Medicines Surges as Big Pharma Circles the Pan-RAS Leader
January 08, 2026
Via
MarketMinute
Topics
Intellectual Property
1 Unpopular Stock That Deserves a Second Chance and 2 We Question
January 07, 2026
Via
StockStory
Ironwood Pharmaceuticals’ 2026 Guidance Shock Sparks a Major Re-Rating
↗
January 07, 2026
Via
MarketBeat
Revolution Medicines Stock Soars On Report Of AbbVie Takeover
↗
January 07, 2026
Via
Stocktwits
Red Spruce Capital Nets $3.7 Million by Dumping One-Third of BSCR Shares
↗
January 07, 2026
Via
The Motley Fool
Topics
Bonds
ETFs
Regulatory Compliance
3 Healthcare Stocks with Exciting Potential
January 06, 2026
Via
StockStory
Topics
Stocks
Top S&P500 movers in Monday's session
↗
January 05, 2026
Via
Chartmill
Flu Season's Here—This Dividend-Payer Controls the Shot Market
↗
January 05, 2026
Via
MarketBeat
Topics
Artificial Intelligence
Death
Uncover the latest developments among S&P500 stocks in today's session.
↗
January 05, 2026
Via
Chartmill
Frequently Asked Questions
Is AbbVie publicly traded?
Yes, AbbVie is publicly traded.
What exchange does AbbVie trade on?
AbbVie trades on the New York Stock Exchange
What is the ticker symbol for AbbVie?
The ticker symbol for AbbVie is ABBV on the New York Stock Exchange
What is the current price of AbbVie?
The current price of AbbVie is 214.35
When was AbbVie last traded?
The last trade of AbbVie was at 01/16/26 07:00 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.